InvestorsHub Logo
Followers 2
Posts 66
Boards Moderated 0
Alias Born 12/03/2012

Re: Blackcat7717 post# 2021

Thursday, 06/20/2013 11:55:10 AM

Thursday, June 20, 2013 11:55:10 AM

Post# of 54032
Blackcat--the reason ITL cancelled the licensing agreement had nothing to do with FDA. It had to do with the fact that TAUG owed $10 million in licensing fees, raised money saying the funds would be used to pay the fees, but then only sent less than half the funds to ITL. That is why we now have tripled our number of shares outstanding and created $12 million in losses over a year instead of investing in curing cancer.

But if it is true that investing in ITL is flushing money down toilet, then that does not bode well for TAUG. With the enormous dilution, high spending, massive stock give aways to insiders, the only hope to make up for the dilution was to create billions in value. The only hope for that was the success of ITL. But since you tell us that ITL is worthless, then there is nothing that supports the current market value of TAUG.

Hopefully, Seth does not agree with your current statements. If he does, I think it is time to exit this.



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.